- CDTX Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
S-3 Filing
Cidara Therapeutics (CDTX) S-3Shelf registration
Filed: 8 Nov 18, 4:08pm
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the reference to our firm under the caption “Experts” in the Registration Statement (FormS-3) and related Prospectuses of Cidara Therapeutics, Inc. for the registration of its common stock, preferred stock, debt securities, and warrants and to the incorporation by reference therein of our report dated February 27, 2018, with respect to the consolidated financial statements of Cidara Therapeutics, Inc. included in its Annual Report (Form10-K) for the year ended December 31, 2017, filed with the Securities and Exchange Commission.
/s/ Ernst & Young LLP |
San Diego, California
November 8, 2018
We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.